Ryman Healthcare Investor News

Investor news

Ryman reports audited full year underlying profit of $224.4 million

Written by David King
on May 21, 2021

Media release – May 21, 2021

Key points:
• Audited underlying profit $224.4 million, 7.3% down due to COVID-19 challenges
• Audited reported (IFRS) profit increased 59.8% to $423.1 million, due to investment property revaluations
• Final dividend of 13.6 cents, taking the full year dividend to 22.4 cents per share, 50% of underlying profit.
• Ryman has returned more than $1.03 billion to shareholders since it listed in 1999, when it raised $25 million
• Record final quarter new sales and resales as market recovers
• Total assets of $9.17 billion, up 19.5%
• Continued strong demand for aged care in New Zealand and Victoria, mature care occupancy at 97%
• Only 1.4% of resale units unsold at the end of March
• Five villages opened in Victoria by December 2020
• Three new sites purchased, one in Melbourne and two in New Zealand
• No cases of COVID-19 to date among 12,500 residents and 6,100 staff across New Zealand and Victoria

Ryman Healthcare has reported a full year underlying profit of $224.4 million, with a second half recovery driven by record sales.

Audited reported (IFRS) profit, which includes unrealised fair value gains on investment property, increased 60% to $423.1 million in the year to March 31, 2021.
Shareholders will receive a final dividend of 13.6 cents per share, taking the total dividend for the year to 22.4 cents per share, which is 50% of underlying profit. The record date for entitlements is June 4, and the dividend will be paid on June 18, 2021.

Chief Executive Gordon MacLeod said transactions and building activity had recovered after a challenging first half due to COVID-19.

“We bore the brunt of the COVID-19 lockdowns in the first half. In the final quarter we achieved record new sales and resales, which was no mean feat after a tough year.’’

“I couldn’t be more proud of how the team has performed – not only to keep COVID-19 out of all of our villages and keep everyone safe – but also to power through and keep on innovating, developing and growing,’’ Mr MacLeod said.

In December Ryman achieved its long-term target of having five villages open in Victoria by the end of 2020, and Ryman has another six villages in the pipeline in Australia.

Ryman has bought new village sites at Essendon in Melbourne, and at Karaka and Cambridge in New Zealand. Ryman has sold its Coburg site in Melbourne after opting to buy a more attractive site in nearby Essendon.

Approval was received to build new villages at Ringwood East in Melbourne, Northwood in Christchurch and two Auckland villages at Takapuna and Kohimarama.
Ryman’s total assets grew by 19.5% during the year. The company has diversified $825 million of debt funding.

A NZ$150 million retail bond issue in New Zealand, a US$300 million USPP private debt placement and an A$250 million institutional term loan were all oversubscribed, Mr MacLeod said.

“The debt issuances allowed us to take our plans to a wider audience of funders and we were delighted with the response. We ended the year with a stronger balance sheet, and new diversified long-term debt funding with weighted average tenor of nine years with plenty of headroom.

“We have had record cash collections of $1.18 billion during the year to support our largest ever building programme, and we are planning to have 14 villages under construction, seven in Australia and seven in New Zealand later this year.

Ryman’s integrated villages and high-quality care continued to be in strong demand, with care occupancy in established villages running at 97%.

Only 1.4% of Ryman’s portfolio was available for resale at March 31, down from 1.9% at September 30, 2020. Ryman built 736 new beds and units during the year.

Chairman Dr David Kerr said a highlight was the response to the COVID-19 vaccine rollout, with both residents and staff jumping at the chance to get vaccinated.

“Getting vaccinated is the best thing anyone can do to keep themselves and their loved ones safe,’’ Dr Kerr said.

“We’re achieving care resident vaccine rates above 95%, which is really pleasing.’’

“Our villages are safe havens for older people where they can expect to live well and with the best of care on hand if they need it. The COVID pandemic has made this security about the future top of mind for older people, and we expect demand will continue to grow.’’

Ryman’s development pipeline of 25 new villages would provide homes for more than 6,800 residents and would generate anticipated capital proceeds of $5.3 billion with recurring income of $420 million, subject to market conditions and consenting outcomes.

“With the vaccine rollout in full swing and huge potential in our pipeline of new villages, we’ve put ourselves in a tremendous position for the years ahead,’’ Dr Kerr said.

Ryman will have returned more than $1.03 billion to shareholders since listing in 1999 after its next dividend is paid on June 18. In 1999 Ryman raised $25 million from investors.

Twelve new villages currently under construction:

New Zealand  Australia
Lynfield, Auckland (Murray Halberg) Brandon Park, Melbourne (Nellie Melba)
Devonport, Auckland (William Sanders) Burwood East, Melbourne (John Flynn)
River Rd, Hamilton (Linda Jones) Highton, Geelong, Victoria (Charles Brownlow)
Lincoln Rd, Auckland (Miriam Corban) Ocean Grove, Victoria
Havelock North, Hawkes Bay (James Wattie) Aberfeldie, Melbourne
Hobsonville, Auckland (Keith Park)  
Riccarton Park, Christchurch  

 

Sites in the land bank:

New Zealand  Australia
Kohimarama, Auckland Highett, Melbourne
Bishopspark/Park Terrace, Christchurch Ringwood East, Melbourne
Northwood, Christchurch Mt Eliza, Victoria
Karori, Wellington Mt Martha, Victoria
Newtown, Wellington Essendon, Melbourne
Takapuna, Auckland  
Karaka, Auckland  
Cambridge, Waikato  

 

About Ryman:

Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 43 retirement villages in New Zealand and Australia. Ryman villages are home to 12,750 residents, and the company employs 6,300 staff.

For investor relations information and enquiries:

Phone: Contact Michelle Perkins, Investor Relations Manager, on 027 222 9684 (+64 27 222 9684)
Email michelle.perkins@rymanhealthcare.com or use the form below.

Share registrar:

Our share register is managed by Link Market Services. Please send a change of personal details or any questions about dividends to enquiries@linkmarketservices.co.nz or phone +64 9 375 5998.

For media information or images:

Contact David King, Corporate Affairs Manager, on 021 499 602 (+64 21 499 602) or email david.king@rymanhealthcare.com

You may also like:

Ryman Healthcare appoints new Group CEO

Media release – September 7, 2021

Record first quarter sales and continued expansion in Melbourne

Media release – July 29, 2021

Ryman Healthcare buys new Essendon site

Media release – May 21, 2021 New A$165 million retirement village planned in Melbourne